Ownership

Mark Ragosa - CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Stock Symbol: KNSA on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Mark Ragosa - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

	Shares	%	Avg Price	Total $
Buys
Sells	-140K	100%	$22.64	-$3.17M
Net	-140K	-100%		-$3.17M

Holdings reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Class A Ordinary Share	26.5K	$537K	$20.28	Apr 7, 2025	Direct
Class A Common Share	19.3K	$344K	$17.88	Apr 26, 2024	Direct
Performance Share Unit	14.8K	$264K	$17.88	Apr 1, 2025	Direct	Class A Ordinary Share
Share Option	29.5K			Apr 1, 2025	Direct	Class A Ordinary Share
Restricted Share Unit	2.69K			Apr 7, 2025	Direct	Class A Ordinary Share
Restricted Share Unit	990			Apr 26, 2024	Direct	Class A Common Share

Transactions reported by Mark Ragosa for Kiniksa Pharmaceuticals International, plc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.